Waters this week named the Center for Proteomics at the Translational Genomics Research Institute as one of its Centers of Innovation.
By a GenomeWeb staff reporter
The downgrades to Illumina and Waters reflect larger worries the investment bank has about the end markets of life science tools firms.
The company said it had borrowed $455 million under the new credit agreement, of which $435 million was used to pay the outstanding amounts from a previous agreement.
The firm's revenues were up 14 percent for the quarter but missed Wall Street's estimates due in part to softness in government and academic research and orders delayed in anticipation of the launch of its new Synapt G2-S mass spec.
Despite the increase in revenues, company officials cited soft government and academic sales, pharma demand that tailed off as the quarter came to a close, and higher than expected SG&A expenses.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
Provided via the EU's Seventh Framework program, the grant will fund proteomics research to be performed by the PRIME-XS consortium, a group of proteomics research teams from 12 European institutes.
Albert Fornace, Amrita Cheema, Dilek Mir, Gregory Critchfield
Agilent, Thermo Fisher Scientific, Waters, NextGen Sciences, Protea Biosciences, Origene
New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.
A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.
Broad Institute researchers describe an approach they've dubbed "DNA microscopy."
In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.